TMCI Treace Medical Concepts
- 6.030
- -0.050-0.82%
- 5.860
- -0.170-2.82%
Treace Medical Concepts News
Treace Medical Concepts(TMCI.US) 10% Shareholder Buys US$264.6K in Common Stock
$Treace Medical Concepts(TMCI.US)$ 10% Shareholder Treace John T. purchased 45,000 shares of common stock on Jun 11, 2024 at an average price of $5.88 for a total value of $264.6K.Source: Announcement
Trending Stocks Today: Annexon Soars 48.03% Post-Market
June 3rd - US stocks trending post-market.Gainers: $Annexon(ANNX.US)$ surges 48.03% to $6.78 with a turnover of $6.07 million. $GameStop(GME.US)$ up 3.14% to $28.88 with a turnover of $58.5 million. $
Treace Medical Concepts(TMCI.US) Director Buys US$151.33K in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director TREACE JAMES T purchased 25,000 shares of common stock on May 31, 2024 at an average price of $6.0531 for a total value of $151.33K.Source: Announcement Wha
Analysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Treace Medical Concepts (TMCI) and Veeva Systems (VEEV)
Treace Medical Concepts(TMCI.US) Director Buys US$130.06K in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director TREACE JAMES T purchased 25,000 shares of common stock on May 29, 2024 at an average price of $5.2025 for a total value of $130.06K.Source: Announcement Wha
Treace Medical Concepts(TMCI.US) Director Buys US$253.47K in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director TREACE JAMES T purchased 50,000 shares of common stock on May 28, 2024 at an average price of $5.0695 for a total value of $253.47K.Source: Announcement Wha
Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing
James T Treace, Director, on May 28, 2024, executed a purchase for 50,000 shares in Treace Medical Concepts (TMCI) for $253,475. Following the Form 4 filing with the SEC, Treace has control over a tot
Treace Medical Concepts(TMCI.US) Director Buys US$93,501 in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director MOTT RICHARD W purchased 18,000 shares of common stock on May 24, 2024 at an average price of $5.1945 for a total value of $93,501.Source: Announcement What
Treace to Present at Truist Securities MedTech Conference
PONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions
Treace Medical Concepts(TMCI.US) Director Buys US$60,424.98 in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director MOTT RICHARD W purchased 12,100 shares of common stock on May 22, 2024 at an average price of $4.9938 for a total value of $60,424.98.Source: Announcement W
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u
Treace Medical Concepts(TMCI.US) 10% Shareholder Buys US$556.17K in Common Stock
$Treace Medical Concepts(TMCI.US)$ 10% Shareholder Treace John T. purchased 100K shares of common stock on May 17, 2024 at an average price of $5.5617 for a total value of $556.17K.Source: Announcemen
Unveiling 6 Analyst Insights On Treace Medical Concepts
Analysts' ratings for Treace Medical Concepts (NASDAQ:TMCI) over the last quarter vary from bullish to bearish, as provided by 6 analysts.The following table summarizes their recent ratings, shedding
UBS Downgrades Treace Medical, Cites Increasing Competition
Treace Medical Concepts Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 11.68% UBS $16 → $6.5 Downgrades Buy → Neutral 05/08/2024 -5.5% Morgan Stanley $15 → $5.5 Downg
Express News | Treace Medical Concepts Inc : UBS Cuts to Neutral From Buy
Express News | Treace Medical Concepts Inc : UBS Cuts Target Price to $6.5 From $16
OPEN, BCRX and AWIN Among Pre-market Gainers
Director Jane Kiernan Acquires 19,356 Shares of Treace Medical Concepts Inc (TMCI)
Treace Medical Concepts(TMCI.US) Director Buys US$100K in Common Stock
$Treace Medical Concepts(TMCI.US)$ Director Kiernan Jane E purchased 19,356 shares of common stock on May 14, 2024 at an average price of $5.1664 for a total value of $100K.Source: Announcement What i
Analysis
Price Target
No Data
